| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |